A Phase II trial of SM04646 in Pulmonary Fibrosis.
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2016
At a glance
- Drugs SM 04646 (Primary)
- Indications Pulmonary fibrosis
- Focus Therapeutic Use
- 13 Nov 2016 New trial record
- 01 Nov 2016 According to a Samumed media release, company is planning to launch this trial in 2016.